Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a completed Phase 3 study of rapastinel as adjunctive therapy for major depressive disorder, with study methods, eligibility criteria, outcomes, locations, and supporting documents.
    Difference
    88%
    Check dated 2026-11-12T11:11:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-29T11:23:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T09:51:32.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision label in the footer advances from v3.7.1 to v3.7.2 while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-15T14:11:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-08T15:17:13.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden message with a minimal header and a Home link, indicating restricted access rather than changes to the study details.
    Difference
    16%
    Check dated 2026-09-24T19:20:04.000Z thumbnail image

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.